Nasal Carriage of and Infection with Staphylococcus aureus in HIV-Infected Patients
- M. Hong Nguyen, MD;
- Carol A. Kauffman, MD;
- Richard P. Goodman, MD;
- Cheryl Squier, RN;
- Robert D. Arbeit, MD;
- Nina Singh, MD;
- Marilyn M. Wagener, MPH; and
- Victor L. Yu, MD
- From University of Pittsburgh Medical Center and Veterans Affairs Medical Center, Pittsburgh, Pennsylvania; University of Michigan Medical Center and Veterans Affairs Medical Center, Ann Arbor, Michigan; and Boston University Medical Center and Veterans Affairs Medical Center, Boston, Massachusetts.
Abstract
Background: Staphylococcus aureus is a common cause of serious infection in patients infected with HIV.
Objectives: To evaluate risk factors for and quantitative effect of S. aureus infection in HIV-infected patients, with special attention to nasal carriage.
Design: Prospective, multihospital cohort study.
Setting: Three tertiary care Veterans Affairs Medical Centers.
Participants: 231 ambulatory HIV-infected patients.
Results: Thirty-four percent of patients were nasal carriers of S. aureus. Of these patients, 38% were persistent carriers and 62% were intermittent carriers. Twenty-one episodes of infection occurred in 13 patients: Ten were bacteremias (including 2 cases of endocarditis), 1 was pneumonia, and 10 were cutaneous or subcutaneous infections. Seventeen (85%) of these episodes occurred in patients with CD4 counts less than 100 cells/mm3. Recurrent infections occurred in 3 of 7 patients who survived an initial S. aureus infection. The mortality rate was higher among patients with S. aureus infection than among those without infection (P = 0.03). Factors significantly associated with S. aureus infection were nasal carriage, presence of a vascular catheter, low CD4 count, and neutropenia. Molecular strain typing indicated that for 6 of 7 infected patients, the strain of S. aureus isolated from the infected sites was the same as that previously cultured from the nares.
Conclusion: Nasal carriage is an important risk factor for S. aureus infection in HIV-infected patients. Controlled studies are indicated to determine whether eradication of nasal carriage in a selected subset of patients (for example, those with a low CD4 cell count) might prevent invasive S. aureus infection in patients with HIV infection.
- Staphylococcus aureus
- Human immunodeficiency virus infections
- Nasal cavity
- Antigens, CD4
- Staphylococcal infections
Article and Author Information
-
Requests for Reprints: Victor L. Yu, MD, Infectious Disease Section (111), Veterans Affairs Medical Center, University Drive C, Pittsburgh, PA 15240; e-mail, vly+@pitt.edu.
-
Current Author Addresses: Dr. Nguyen: University of Florida College of Medicine, Box 100277, JHMHC, Gainesville, FL 32610.
-
Dr. Kauffman: Division of Infectious Diseases, Veterans Affairs Medical Center, 2215 Fuller Road, Ann Arbor, MI 48105.
-
Drs. Goodman and Arbeit: Veterans Affairs Medical Center, 150 S. Huntington Avenue, 111 ID, Boston, MA 02130.
-
Ms. Squier, Dr. Singh, Ms. Wagener, and Dr. Yu: Infectious Disease Section (111), Veterans Affairs Medical Center, University Drive C, Pittsburgh, PA 15240.
- Copyright ©2004 by the American College of Physicians
RSS Feeds









